COVID-19 vaccination in the United Kingdom

From Infogalactic: the planetary knowledge core
Jump to: navigation, search

Lua error in package.lua at line 80: module 'strict' not found.

COVID-19 vaccination programme
350px
Map of the UK showing total cumulative vaccination numbers per population of the region as of 7 April 2021 [1]
Date 8 December 2020 (2020-12-08) – present
Location United Kingdom
Cause COVID-19 pandemic
Participants 46,159,145 have received one vaccine dose
35,543,321 have received both vaccine doses[2]
Outcome 87.6% of the UK adult population have received one vaccine dose
67.5% of the UK adult population have received both vaccine doses[3]
Website www.gov.uk/government/collections/covid-19-vaccination-programme
File:Graph of first doses as of 30 may 2021 UK Vaccines COVID.png
The percentage of the adult population, by nation, reported to have received 1st dose of a vaccine as of 30 May 2021
File:COVID-19 Vaccination Centre (general Practice) December 2020.jpg
GP-led vaccination centres were in operation by 15 December 2020

The COVID-19 vaccination programme in the United Kingdom is an ongoing mass immunisation campaign for COVID-19 during the pandemic in the United Kingdom. The UK's vaccination rollout was the world's first mass immunisation programme for the disease when it began on 8 December 2020 after Margaret Keenan received her first dose of two. As of 15 July 2021, 46,159,145 first doses and 35,543,321 second doses of a vaccine had been administered across the UK.[2]

Vaccinations began on 8 December 2020. There are three vaccines currently in use, developed by respective partnerships between Pfizer and BioNTech (Comirnaty), the University of Oxford and AstraZeneca (AZD1222), and the United States National Institute of Allergy and Infectious Diseases and Moderna (MRNA-1273). As of 8 May 2021, there were five other COVID-19 vaccines on order for the programme, at varying stages of development.

Phase 1 of the rollout prioritises the most vulnerable, in a schedule primarily based on age. The delivery plan was adjusted on 30 December 2020, delaying second doses so that more people could receive their first dose. A target to give all 15 million people in the top four priority groups their first dose by the middle of February 2021 was announced on 4 January 2021, and achieved on 14 February 2021. The next five groups were offered a vaccine by 15 April, and 32 million doses were administered by that point. In June 2021, all adults aged 18+ were able to get their first dose of the vaccine.

Vaccination sites include GP practices, care homes and pharmacies, as well as hospitals. As of 21 May 2021, there were 2,057 vaccination sites operating in England.[4] There are over 1,100 vaccination sites operating in Scotland.[5] As of 25 May 2021, there were 462 vaccination sites operating in Wales.[6] Additional sites, including large venues such as sports stadia, entered the programme from 11 January 2021, with seven mass vaccination centres opening in England initially and seven in Wales.[7]

New guidance for allergy sufferers, antibody tests, new variants of SARS-CoV-2 (B.1.1.7 & B.1.617) and the use of the University of Oxford and AstraZeneca (AZD1222) vaccine in younger adults have been issued throughout the programme.

The programme also includes procurement of vaccines for British Overseas Territories and Crown Dependencies.[8][9]

Progress, as of 8 July 2021
Home nation Doses administered per 100 people
 United Kingdom
119.87
 England
119.28
 Scotland
123.65
 Wales
129.05
 Northern Ireland
111.31

From official vaccination[10] and 2019 ONS[11][12][13][14] data.
(Doses may not equate to no. people if more than one dose received.)

Background

Responsibility for COVID-19 vaccine deployment

On 28 November 2020 the new role of Parliamentary Under-Secretary of State for COVID-19 Vaccine Deployment was set up within the Department of Health and Social Care in the Government of the United Kingdom, with Nadhim Zahawi the first to take office.[15]

Vaccines on order

There are several COVID-19 vaccines at various stages of development around the world. As of 7 February 2021 the British Government had placed orders for a combined total of 457 million doses across 8 different vaccines.[16][17][18][19] As of 28 April 2021, this total had increased to 507 million doses.[20] This does not equate to the number of people that can be immunised as most vaccines require more than one dose. The breakdown of the vaccines being considered for the vaccination programme is as follows:[21][22]

Vaccine Origin Progress Doses ordered Approval Deployment
Pfizer–BioNTech US/Germany phase III clinical trials 100 million[23] Template:Yes C Template:Yes C
Oxford-AstraZeneca UK/Sweden/India phase III clinical trials 100 million Template:Yes C[24] Template:Yes C[25]
Moderna US phase III clinical trials 17 million[17] Template:Yes C[17] Template:Yes C[26]
Janssen (Johnson & Johnson) US/Belgium/Netherlands phase III clinical trials 20 million Template:Yes C[27] Pending
Novavax US/India phase III clinical trials 60 million Pending Pending
Valneva EU/UK/Canada/US phase III clinical trials 100 million[18] Pending Pending
GSK/Sanofi Pasteur UK/France phase I/II clinical trials 60 million Pending Pending
CureVac Germany phase III clinical trials 50 million[19] Pending Pending

History

Regulatory approvals

On 2 December 2020, the UK became the first country to give approval for use of the Pfizer–BioNTech vaccine,[28][29] later branded as Comirnaty.[30] This was in the form of a temporary authorisation given by the Medicines and Healthcare products Regulatory Agency (MHRA) under Regulation 174 of the Human Medicines Regulations 2012.[31] Regulatory approval is reserved under the devolution settlement. The first batch arrived in the UK the next day and was initially stored at an undisclosed central hub before being distributed to hospital vaccination centres across the country.[32]

On 30 December 2020, the UK also became the first country to approve the Oxford/AstraZeneca vaccine.[24]

On 8 January 2021, the Moderna vaccine was approved as the third vaccine to enter the programme.[17]

On 28 January 2021, the results of the Novavax vaccine trials, which were undertaken in the UK and in South Africa, showed it was 95.6% effective against the original SARS-CoV-2 strains and 85.6% against the Variant of Concern 202012/01, then prevalent in the UK. The company stated it had begun the process of requesting clearance for use in the UK.[33] The Novavax vaccine was the first to be tested in clinical trials for efficacy against the UK's prevailing Variant of Concern 202012/01.[34] In clinical trial subjects without HIV infections, the vaccine was also 60% effective against the 501.V2 variant, a SARS-CoV-2 strain first detected in South Africa.[34]

On 28 May 2021, the Janssen vaccine was the fourth Vaccine to be approved in the UK.[27]

Rollout timeline

This timeline lists the general availability of vaccine appointments in England, by date. The exact dates differed slightly in Scotland, Wales and Northern Ireland (not listed here).

Availability of vaccine appointments in England, by date
Start date Appointments available for Priority

group

 Ref
8 December 2020 Residents in a care home for older adults and their carers; and all aged 80 and over 1 and part of 2 [35][36]
Procedures set out on 9 and 14 January 2021 Frontline health and social care workers Part of 2 [37][38]
18 January 2021 All aged 70 and over, and clinically extremely vulnerable individuals 3 and 4 [39]
15 February 2021 All aged 65 and over; and those aged 16 to 64 with underlying health conditions which put them at higher risk of serious disease and mortality 5 and 6 [40]
1 March 2021 All aged 60 and over 7 [41]
6 March 2021 All aged 56 and over 8 (age adjusted from 55) [42]
17 March 2021 All aged 50 and over 9 [43]
13 April 2021 All aged 45 and over [44]
26 April 2021 All aged 44 and over [45]
27 April 2021 All aged 42 and over [46]
30 April 2021 All aged 40 and over [47]
13 May 2021 All aged 38 and over [48]
18 May 2021 All aged 36 and over [49]
20 May 2021 All aged 34 and over [50]
22 May 2021 All aged 32 and over [51]
26 May 2021 All aged 30 and over [52]
8 June 2021 All aged 25 and over [53]
15 June 2021 All aged 23 and over [54]
16 June 2021 All aged 21 and over [55]
18 June 2021 All adults (ie aged 18 and over) [56]
File:Wentworth Avenue vaccination centre, Finchley, London N3 4 March 2020 01.jpg
A vaccination centre in Finchley, north London, March 2021

On 8 December 2020, Margaret Keenan, 90, became the first person in the world (outside trials) to receive the Pfizer–BioNTech vaccine as the rollout of vaccinations began.[35] William Shakespeare, 81, from Warwickshire became the second person, and the first man, to be vaccinated.[57] Both vaccinations took place at University Hospital Coventry. On 4 January 2021, Brian Pinker, 82, became the first person (outside trials) to receive the Oxford–AstraZeneca vaccine. The vaccination took place at the Churchill Hospital, Oxford.[25] England Health Secretary, Matt Hancock said this was a "pivotal moment" in the programme as this vaccine was easier to transport and store, requiring only ordinary fridge temperatures. Six hospitals in England began the Oxford vaccine rollout using the first batch of around 530,000 doses.[58]

The Queen, then 94, and the late Prince Philip, 99, received their vaccinations within their Windsor Castle residence on 9 January 2021.[59] Prince William cited their example, a week later, to encourage everyone to take up the vaccine[60] after hearing that a degree of vaccine hesitancy had set in.

The rollout to the over 70s and clinically extremely vulnerable began on 18 January 2021,[39] representing the fourth priority group and the final group needed to complete the government's initial 15 February target.[61]

Over 20 million first doses were administered by 28 February 2021.[62]

On 20 March, Prime Minister Boris Johnson received his first dose of the AstraZeneca vaccine at St. Thomas' Hospital. By this point, more than 26 million people had received their first dose of a COVID-19 Vaccine.[63]

On 7 April 2021, Elle Taylor, 24, became the first person in the UK (outside trials) to receive the Moderna vaccine. The vaccine was administered on Miss Taylor, an unpaid carer from Ammanford, at Glangwili General Hospital, Carmarthen.[64]

Guidance

File:Wentworth Avenue vaccination centre, Finchley, London N3 4 March 2021 04.jpg
Queuing for the Oxford-AstraZeneca vaccine in Finchley, North London, March 2021

On 9 December 2020, the MHRA issued updated guidance, after two cases of anaphylaxis and another case of a possible allergic reaction following the vaccination. In the statement, June Raine, MHRA Chief Executive said:[65] <templatestyles src="Template:Blockquote/styles.css" />

Any person with a history of anaphylaxis to a vaccine, medicine or food should not receive the Pfizer/BioNTech vaccine. A second dose should not be given to anyone who has experienced anaphylaxis following administration of the first dose of this vaccine.

Raine went on to say that such side effects have been known to happen with any vaccine but are "very rare". She continued to confirm that existing appointments should not be cancelled but people with a history of serious allergies should discuss this beforehand. Furthermore, she expressed confidence in the safety, assessment and monitoring of the vaccine. Guidance was given that vaccine recipients should be monitored for at least 15 minutes after vaccination and centres must be prepared for such events including the availability of an anaphylaxis pack.[65] The two people affected were quickly treated and recovered well.[65]

The Department of Health and Social Care confirm that although the vaccine triggers the creation of antibodies, vaccination does not affect the result of an antibody test to detect whether someone has previously contracted the virus. This is because there are differences between the antibodies triggered and those being tested for.[66]

As of 20 December 2020, Public Health England say there is "no evidence" to suggest that the recently identified Variant of Concern 202012/01 (a new variant of SARS-CoV-2) would be resistant to the Pfizer–BioNTech vaccine currently being used in the programme, and people should still be protected.[67] Further laboratory work is still being prioritised to increase current understanding of this.

As of 8 April 2021, the JCVI issued advice to the government stating "that it is preferable for adults aged under 30 with no underlying conditions to be offered an alternative to the Oxford-AstraZeneca vaccine where available, following reports of extremely rare blood clots in a very small number of people."[68]

As of 7 May 2021, the JCVI issued advice to the government stating "the JCVI has advised a preference for adults aged 30 to 39 without underlying health conditions to receive an alternative to the Oxford/AstraZeneca vaccine – where available and only if this does not cause substantial delays in being vaccinated, on extremely rare cases of concurrent thrombosis (blood clots) and thrombocytopenia (low platelet count) following the first dose of the Oxford/AstraZeneca vaccine."[69]

As of 16 June 2021 it is expected that vaccination will become mandatory for those working in aged care (excluding those medically exempt).[55]

Organisations involved

In the months before approval of the first vaccine, the Joint Committee on Vaccination and Immunisation (an independent group of experts) gave advice to the Vaccine Taskforce on the groups of people that should be prioritised for vaccination.[70][71] The taskforce was formed in May 2020 to lead efforts to develop, manufacture and procure vaccines for the UK and globally,[72] and was led until the end of 2020 by biotech venture capital manager Kate Bingham.[73]

As with other licensed vaccines, the National Institute for Biological Standards and Control (part of the MHRA) reviews the production process and the manufacturer's quality control, and tests each batch of vaccine.[74] Again in common with other vaccines and medicines, the MHRA monitors adverse reactions by collecting details submitted by healthcare workers, carers and the public through the Yellow Card Scheme; the agency set up a web reporting site specific to the COVID-19 vaccines.[75]

The creation of the Vaccines Manufacturing and Innovation Centre was announced in December 2018, to provide the UK with a vaccine development and manufacturing facility, and its building is under construction at Harwell with planned completion brought forward from 2022 to 2021. The academic/industrial consortium assisted with development and early production of the Oxford–AstraZeneca vaccine during 2020.[76]

Planning

File:COVID-19 AstraZeneca Vaccine vial and NHS record card.jpg
AstraZeneca vaccine vial and a NHS patient COVID-19 vaccination record card at a NHS vaccination centre

Delivery plan

During the rollout of the Pfizer–BioNTech vaccine first doses, the UK government announced on 30 December 2020 that future deployment would focus on that initial dose, rather than giving the required two doses as quickly as possible. The announcement of this plan coincided with the approval of the Oxford–AstraZeneca vaccine, and so represents the strategy to rollout the two vaccines. The government stated that prioritising the first dose was on advice from the Joint Committee on Vaccination and Immunisation (JCVI) and further assured that everyone would still receive their second dose within 12 weeks of their first.[24] Despite this, Margaret Keenan, who was the first person outside of trials to receive a dose of the Pfizer–BioNTech vaccine, returned to hospital on 29 December 2020 for her follow-up injection. This was exactly three weeks after her first, in accordance with the original plan until the announcement of the new strategy. By receiving her second dose, Keenan completed the vaccination process.[77]

The new plan to increase the gap between first and second doses from 3 to 12 weeks, was criticised as "unfair" by the British Medical Association (BMA) on 31 December 2020, as appointments booked for 4 January 2021 or later would have to be rescheduled.[78] In response, all four Chief Medical Officers (CMO), plus England's Deputy CMO Jonathan Van-Tam, signed an open letter explaining the policy shift.[79] They said by prioritising first doses, more people would have substantial protection faster, and the second dose adds relatively minor additional protection in the short term. They went on to say that for every 1,000 people given the second 'booster' dose, 1,000 new people would not be able to have up to 70% protection and would instead remain totally unprotected.

Delivery targets

During his address announcing England's third national lockdown on 4 January 2021, Boris Johnson indicated a preliminary target for the vaccination programme, saying:[61]

<templatestyles src="Template:Blockquote/styles.css" />

By the middle of February, if things go well and with a fair wind in our sails, we expect to have offered the first vaccine dose to everyone in the four top priority groups identified by the Joint Committee on Vaccination and Immunisation.

He went on to confirm this would include all elderly residents of care homes and indeed everyone over the age of 70, as well as all frontline health and social care workers, and all those who are "clinically extremely vulnerable".

Vaughan Gething, Minister for Health and Social Services in the Welsh Government, matched England's targets by announcing that all people in groups 1–4 would be offered a first dose by mid February.[80]

A vaccination plan was published by the Scottish Government on 14 January.[81] Part of this plan, subsequently withdrawn after objections from central government, projected the numbers of doses of vaccines delivered weekly to Scotland from the British Government until May, estimating that by mid-March there would be enough doses there to supply every person in the priority groups with their first doses, and enough doses by July to supply every adult with both doses.[82] Extrapolating from these figures, Sky News estimated that supply for the UK overall would be sufficient to meet the British Government's aim of immunising all 15 million priority individuals in the country by mid-February, and vaccinating all adults in Britain with their first dose by mid-July.[82]

Vaccine priority groups

File:Cymar House Care Home, Pontefract Road, Castleford, West Yorkshire (24th April 2021) 002.jpg
A care home in Castleford, West Yorkshire with sign reading "Proud to be Covid(sic) Vaccinated"

Phase 1

The JCVI advised the governments on how to prioritise the rollout. The top priority for the programme was to prevent deaths and to ensure that the National Health Service (NHS) would not be overwhelmed, and as older people are more at risk of hospitalisation or death from COVID-19, prioritisation was primarily based on age.[83]

The table shows the priority groups for the first phase of the roll-out.[83] An estimate of the number of people in each group in the United Kingdom is also shown[84] (but note that some people fall into more than one group).

Order Priority group Number eligible (estimated)[84]
1 residents in a care home for older adults and their carers 0.8M
2 all those 80 years of age and over, and frontline health and social care workers 7.1M
3 all those 75 years of age and over 2.3M
4 all those 70 years of age and over, and clinically extremely vulnerable individuals 4.4M
5 all those 65 years of age and over 2.9M
6 all those aged 16 years to 64 years with underlying health conditions which put them at higher risk of serious disease and mortality 7.3M
7 all those 60 years of age and over 1.8M
8 all those 55 years of age and over 2.4M
9 all those 50 years of age and over 2.8M
File:UK vaccine priority groups.svg
Breakdown of sizes of high-priority groups for COVID-19 vaccination in the UK[85]

"Clinically extremely vulnerable" is defined as:[86]

Women who are pregnant and children under 16 are not defined as clinically extremely vulnerable for the purpose of the vaccination programme.[83]

Polish group Omni Calculator developed a tool which estimates when individuals will receive the vaccine, based on age, employment, and health status.[87][88][89]

"People with underlying health conditions which put them at higher risk of serious disease and mortality" is defined as:[90]

[83]

Phase 2

The JCVI released an interim statement on 26 February 2021 regarding the rollout of the vaccine in Phase 2. It was decided that Phase 2 would not rollout by occupation or ethnicity but instead solely on age. The order therefore in Phase 2 is as follows:[91]

Order Priority group Number eligible (estimated)
10 all those 40 to 49 years of age ~21 million[92]
11 all those 30 to 39 years of age
12 all those 18 to 29 years of age

The JCVI also noted that males from BAME backgrounds and those with a BMI over 30 were at an increased risk, and therefore stated that it "strongly advises that individuals in these groups promptly take up the offer of vaccination when they are offered", with local officials advised to "promote vaccination in these groups".[91] Poorer neighbourhoods should also be subject to an outreach programme by local officials. The UK government said it aimed to offer all adults over the age of 18 a vaccine before 31 July 2021.[92]

The decision not to prioritise people in high-risk public-facing occupations such as teachers, police officers and bus drivers was criticised by the Association of School and College Leaders, NASUWT and the Metropolitan Police Federation. Asthma UK also criticised the lack of prioritisation of those with mild or moderate asthma in either Phase 1 or Phase 2.[92] JCVI chair Wei Shen Lim defended the rollout plan, stating "speed of deployment is the most important factor" and that rollout by occupation would slow down vaccinations.[92]

Progress to date

Imports and exports

In six weeks 10 million doses have been imported in the UK from the European Union. Whilst the UK government has not explicitly banned exports of vaccine doses from the UK, there is no evidence of any vaccine exports having taken place.[93]

In March 2021, due to the lower supply of vaccines within the EU, the European Commission was considering the possibility to ban exports to countries that have a higher rate of vaccination.[93]

Other progress

Lua error in package.lua at line 80: module 'strict' not found. Template:COVID-19 pandemic data/United Kingdom vaccinations chart Template:COVID-19 pandemic data/United Kingdom vaccinations daily chart Template:COVID-19 pandemic data/United Kingdom vaccinations weekly by nation chart By the end of the first full week of the programme, up to 15 December 2020, 137,897 people had been vaccinated with the first dose in the two-dose regimen: 108,000 in England, 7,897 in Wales, 4,000 in Northern Ireland and 18,000 in Scotland.[94][95]

By 5 January 2021, 1.3 million people across the UK had received their first dose of either the Pfizer or Oxford–AstraZeneca COVID-19 vaccine, which included more than 650,000 people over 80, representing around 23% of that age band in England.[96]

As of 22 February 2021, a cumulative total of 17,916,181 people had received the first dose: 15,113,158 in England; 468,129 in Northern Ireland; 1,465,241 in Scotland and 869,653 in Wales. In addition, a cumulative total of 642,788 people had received the second dose: 518,779 in England; 31,077 in Northern Ireland; 43,203 in Scotland and 49,729 in Wales.[97]

Government vaccination updates increased from weekly to daily, from 11 January 2021.[96]

Weekly new and cumulative doses, by dose type, as at each week-ending date[97]
Previous WEEKLY figures  England  Northern Ireland  Scotland  Wales UK TOTAL
Date Dose New Cumulative New Cumulative New Cumulative New Cumulative New Cumulative
13 December 2020 1st 55,389[lower-roman 1] 55,389 3,623 3,623 18,996 18,996 8,207 8,207 86,215 86,215
20 December 2020 1st 518,469 573,858 12,445 16,068 41,110 60,106 15,559 23,766 587,583 673,798
27 December 2020 1st 267,347 841,205 14,948 31,016 34,404 94,510 12,433 36,199 392,132 1,002,930
3 January 2021 1st 328,980 1,170,185 9,669 40,685 21,321 115,831 14,094 50,293 374,064 1,376,994
2nd 20,565 20,565 1,271 1,271 43 43 26 26 21,905 21,905
Total 349,545 1,190,750 10,940 41,956 21,364 115,874 14,120 50,319 395,969 1,398,899
10 January 2021 1st 951,951 2,122,136 38,395 79,080 51,109 166,940 41,212 91,505 1,082,667 2,459,661
2nd 384,998 405,563 12,287 13,558 2,794 2,837 59 85 400,138 422,043
Total 1,336,949 2,527,699 50,682 92,638 53,903 169,777 41,271 91,590 1,482,805 2,881,704
17 January 2021 1st 1,606,125 3,728,261 46,637 125,717 104,469 271,409 67,237 158,742 1,824,468 4,284,129
2nd 40,372 445935 8,768 22,326 1,102 3,939 113 198 50,355 472,398
Total 1,646,497 4,174,196 55,405 148,043 105,571 275,348 67,350 158,940 1,874,823 4,756,527
24 January 2021 1st 2,238,615 5,966,876 33,925 159,642 153,238 424,647 124,251 282,993 2,550,029 6,834,158
2nd 6,480 452,415 387 22,713 2,049 5,988 370 568 9,286 481,684
Total 2,245,095 6,419,291 34,312 182,355 155,287 430,635 124,621 283,561 2,559,315 7,315,842
31 January 2021 1st 2,189,803 8,156,679 62,167 221,809 164,922 589,569 160,504 443,497 2,577,396 9,411,554
2nd 8,349 460,764 1,899 24,612 2,492 8,480 381 949 13,121 494,805
Total 2,198,152 8,617,443 64,066 246,421 167,414 598,049 160,885 444,446 2,590,517 9,906,359
7 February 2021 1st 2,367,095 10,523,774 81,669 303,478 277,254 866,823 167,361 610,858 2,893,379 12,304,933
2nd 8,395 469,159 2,851 27,463 3,038 11,518 1,872 2,821 16,156 510,961
Total 2,375,490 10,992,933 84,520 330,941 280,292 878,431 169,233 613,679 2,909,535 12,815,894
14 February 2021 1st 2,343,180 12,862,909 93,765 397,243 388,367 1,255,190 180,833 784,809 3,006,145 15,300,151
2nd 19,086 490,722 1,542 29,005 3,811 14,501 2,610 5,402 27,049 539,630
Total 2,362,266 13,353,631 95,307 426,248 392,178 1,269,691 183,443 790,211 3,033,194 15,839,781
21 February 2021 1st 2,095,165 14,958,074 60,787 458,030 190,298 1,445,488 77,439 862,248 2,423,689 17,723,840
2nd 22,713 513,435 1,791 30,796 22,841 37,342 37,350 42,752 84,695 624,325
Total 2,117,878 15,471,509 62,578 488,826 213,139 1,482,830 114,789 905,000 2,508,384 18,348,165
28 February 2021 1st 2,254,730 17,212,804 67,370 525,400 166,090 1,611,578 63,421 925,669 2,551,611 20,275,451
2nd 86,500 599,935 2,401 33,197 41,523 78,865 61,067 103,819 191,491 815,816
Total 2,341,230 17,812,739 69,771 558,597 207,613 1,690,443 124,488 1,029,488 2,743,102 21,091,267
7 March 2021 1st 1,802,693 19,015,497 63,403 588,803 163,081 1,774,659 72,627 998,296 2,101,804 22,377,255
2nd 197,386 797,321 9,654 42,851 39,867 118,732 79,920 183,739 326,827 1,142,643
Total 2,000,079 19,812,818 73,057 631,654 202,948 1,893,391 152,547 1,182,035 2,428,631 23,519,898
14 March 2021 1st 1,776,341 20,791,838 40,658 629,461 134,332 1,908,991 124,635 1,122,931 2,075,966 24,453,221
2nd 332,123 1,129,444 11,785 54,636 43,213 161,945 80,516 264,255 467,637 1,610,280
Total 2,108,464 21,921,282 52,443 684,097 177,545 2,070,936 205,151 1,387,186 2,543,603 26,063,501
21 March 2021 1st 3,063,024 23,854,862 58,067 687,528 273,409 2,182,400 150,255 1,273,186 3,544,755 27,997,976
2nd 492,103 1,621,547 34,047 88,683 63,151 225,096 81,803 346,058 671,104 2,281,384
Total 3,555,127 25,476,409 92,114 776,211 336,560 2,407,496 232,058 1,619,244 4,215,859 30,279,360

Vaccination centres

File:COVID-19 vaccine marshalling at Wetherby Health Centre (30th January 2021) 002.jpg
Marshalling for COVID-19 vaccines at a medical centre in Wetherby, West Yorkshire.

More than 70 sites across the UK were in operation at the end of the programme's first full week (15 December 2020). Whilst hospitals formed the centres initially, GP-led centres also started later in that week.[98]

Care home locations in England entered the programme on Wednesday 16 December. "Hundreds" of residents received the first dose in seven care homes in Slough, Aintree, Herne Bay, Thanet, Chalfont St Peter, Droitwich and Cheltenham.[99] Larger care homes (50 to 70 beds) were to be prioritised.[99]

The Chelsea Pensioners received their first dose at the Royal Hospital Chelsea on 23 December.[100]

Large venues such as sports stadia and exhibition centres started to be used as mass vaccination centres from 11 January 2021,[96] with seven such centres opening in England at Millennium Point, Birmingham; Ashton Gate Stadium, Bristol; ExCeL London; Manchester Tennis and Football Centre; Centre for Life, Newcastle; Robertson House, Stevenage; and Epsom Downs Racecourse, Surrey.[101] Seven mass vaccination centres were initially opened in Wales with that number increasing to 34 by February alongside 17 acute and community hospital sites.[7][102]

Over 400 GP-led centres were rolling out the vaccination in Wales by the start of February.[102]

High street pharmacies in England started to administer the vaccine from 14 January 2021, with 6 chosen for the roll out initially.[103]

Places of worship also started to be used as large vaccination centres, with Salisbury Cathedral[104] and Lichfield Cathedral[105] among the first to make provisions from 15 January 2021; with the Al-Abbas Islamic Centre in Balsall Heath, Birmingham becoming the first mosque to offer the service on 21 January 2021.[106]

Locations

As of 28 May 2021, there were a total of 1,992 vaccination sites operating in England,[lower-roman 2] These were made up as follows:[107]

Number of vaccination sites in England, by region and type, as of 28 May 2021[107]
Region Hospital hubs GP-Led vaccination services Mass vaccination centres Pharmacies Totals
East of England 31 134 50 40 255
London 51 103 35 109 298
Midlands 40 189 20 96 345
North East and Yorkshire 46 173 17 96 332
North West 49 137 11 63 260
South East 39 180 18 66 303
South West 21 111 13 54 199
Grand Total 277 1,027 164 524 1992
  • Coronavirus vaccination centres in Wales 15-01-21.png

    Vaccination site locations in Wales, as at 15 January 2021

  • Map of COVID-19 vaccination sites in England.pdf

    Vaccination site locations in England, as at 5 February 2021

  • Scotland COVID-19 vaccine deployment plan 14 January 2021 (page 11 crop) - Centres Map.jpg

    Vaccination site locations in Scotland, as at 14 January 2021

See also

Notes

  1. ↑ England vaccination uptake data not published until 15 December 2020, so carried forward to next week ending
  2. ↑ As of the stated date, location data for Scotland, Wales and Northern Ireland has not been published by the respective devolved authorities.

References

  1. ↑ UK COVID-19 Vaccine Tracker: Nations Map. By George Karabassis.
  2. ↑ 2.0 2.1 Lua error in package.lua at line 80: module 'strict' not found.
  3. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  4. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  5. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  6. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  7. ↑ 7.0 7.1 Lua error in package.lua at line 80: module 'strict' not found.
  8. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  9. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  10. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  11. ↑ Template:NOMIS
  12. ↑ Template:NOMIS
  13. ↑ Template:NOMIS
  14. ↑ Template:NOMIS
  15. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  16. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  17. ↑ 17.0 17.1 17.2 17.3 Lua error in package.lua at line 80: module 'strict' not found.
  18. ↑ 18.0 18.1 Lua error in package.lua at line 80: module 'strict' not found.
  19. ↑ 19.0 19.1 Lua error in package.lua at line 80: module 'strict' not found.
  20. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  21. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  22. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  23. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  24. ↑ 24.0 24.1 24.2 Lua error in package.lua at line 80: module 'strict' not found.
  25. ↑ 25.0 25.1 Lua error in package.lua at line 80: module 'strict' not found.
  26. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  27. ↑ 27.0 27.1 Lua error in package.lua at line 80: module 'strict' not found.
  28. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  29. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  30. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  31. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  32. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  33. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  34. ↑ 34.0 34.1 Lua error in package.lua at line 80: module 'strict' not found.
  35. ↑ 35.0 35.1 Lua error in package.lua at line 80: module 'strict' not found.
  36. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  37. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  38. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  39. ↑ 39.0 39.1 Lua error in package.lua at line 80: module 'strict' not found.
  40. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  41. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  42. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  43. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  44. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  45. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  46. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  47. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  48. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  49. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  50. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  51. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  52. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  53. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  54. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  55. ↑ 55.0 55.1 Lua error in package.lua at line 80: module 'strict' not found.
  56. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  57. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  58. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  59. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  60. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  61. ↑ 61.0 61.1 Lua error in package.lua at line 80: module 'strict' not found.
  62. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  63. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  64. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  65. ↑ 65.0 65.1 65.2 Lua error in package.lua at line 80: module 'strict' not found.
  66. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  67. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  68. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  69. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  70. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  71. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  72. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  73. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  74. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  75. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  76. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  77. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  78. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  79. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  80. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  81. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  82. ↑ 82.0 82.1 Lua error in package.lua at line 80: module 'strict' not found.
  83. ↑ 83.0 83.1 83.2 83.3 Lua error in package.lua at line 80: module 'strict' not found.
  84. ↑ 84.0 84.1 Lua error in package.lua at line 80: module 'strict' not found.
  85. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  86. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  87. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  88. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  89. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  90. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  91. ↑ 91.0 91.1 Lua error in package.lua at line 80: module 'strict' not found.
  92. ↑ 92.0 92.1 92.2 92.3 Lua error in package.lua at line 80: module 'strict' not found.
  93. ↑ 93.0 93.1 Lua error in package.lua at line 80: module 'strict' not found.
  94. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  95. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  96. ↑ 96.0 96.1 96.2 Lua error in package.lua at line 80: module 'strict' not found.
  97. ↑ 97.0 97.1 Lua error in package.lua at line 80: module 'strict' not found.
  98. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  99. ↑ 99.0 99.1 Lua error in package.lua at line 80: module 'strict' not found.
  100. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  101. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  102. ↑ 102.0 102.1 Lua error in package.lua at line 80: module 'strict' not found.
  103. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  104. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  105. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  106. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  107. ↑ 107.0 107.1 Lua error in package.lua at line 80: module 'strict' not found.

External links

Retrieved from "https://infogalactic.com/w/index.php?title=COVID-19_vaccination_in_the_United_Kingdom&oldid=726235986"